Tag: form

Featuring Sukre™ for GLUT-4 Receptor Support, Gluco6 Highlights Non-Synthetic Compounds and 2025 Trends in Plant-Based Glucose Wellness

Now Reformulated With InnoSlim®, α-Lacys Reset®, and Capsimax® to Support Multi-Pathway Metabolic Function Without a Prescription

NEW YORK, July 03, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Rocket Pharmaceuticals, Inc. ("Rocket" or the "Company") (NASDAQ: RCKT) of a class action securities lawsuit.

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, July 03, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on July 1, 2025 (the “Grant Date”), ORIC granted a total of 9,000 non-qualified stock options and 1,600 restricted stock units to one new non-executive employee who began their employment with ORIC in June 2025.

NEW YORK, July 03, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Designer Brands Inc. (NYSE: DBI) resulting from allegations that Designer Brands may have issued materially misleading business information to the investing public.

Singapore, July 03, 2025 (GLOBE NEWSWIRE) -- The UPCX innovative open-source blockchain payment platform has announced a new staking event, offering a total reward pool of up to 10,000 UPC (approximately $38,000). The event will run fromJuly 1, 2025, to July 31, 2025, aiming to reward community supporters while promoting the continued development and long-term goals of the UPCX ecosystem.

 

UPCX leverages highly optimized blockchain technology, focusing on fast transactions, high security, and cross-chain interoperability to provide a seamless and convenient payment experience for users, merchants, and institutions. Its governance token,UPC, has been successfully listed on Japan’s compliant exchange BitTrade, as well as prominent platforms such as MEXC, Bitget, Gate.io, WEEX, and Websea.

How to Participate in the UPCX Staking Event

Event Period: July 1, 2025 – July 31, 2025

Official Staking Platform:https://upcx-staking.io/

Reward Claim Form:https://forms.gle/SYs8TwS8jVThEVcf7

Participation Steps

1. Visit the Official Staking PlatformGo to the UPCX official staking platform and connect your wallet.
2. Select Staking Amount and Lockup PeriodEnter the amount of UPC you wish to stake.   Available lockup periods:30 days,90 days, or180 days. Longer lockup periods offer higher reward coefficients.
3. Complete Authorization and Staking

First, complete the[Approve]authorization.
Then, click[Stake Now]to stake and confirm the transaction.
Gas fees incurred during authorization and staking will be reimbursed in equivalent $UPC to your staking wallet address after the event ends.

4. Submit Reward Claim InformationAfter staking, fill out the official reward claim form with your staking details and wallet address to ensure smooth reward distribution.
5. Await Reward DistributionAfter the event concludes, rewards will be distributed to your staking wallet based on the staked amount and lockup period.

The UPCX team reserves the right to the final interpretation of the event. For any questions, please contact official customer support or join the official community for assistance.

Reward Rules

1. Standard Reward Pool

Stake >10 UPC: Share1,500 UPC

Stake >500 UPC: Share2,500 UPC

Stake >1,000 UPC: Share4,000 UPC

2. Long-Term Lockup Bonus Pool

Stake ≥25 UPC, lock for 90 days: Share400 UPC

Stake ≥25 UPC, lock for 180 days: Share600 UPC

More about UPCX:

UPCX is a blockchain-based open-source payment platform that aims to provide secure, transparent, and compliant financial services to global users. It supports fast payments, smart contracts, cross-asset transactions, user-issued assets (UIA), non-fungible tokens (NFA), and stablecoins. Moreover, it offers a decentralized exchange (DEX), APIs, and SDKs, allows customized payment solutions, and integrates POS applications and hardware wallets for enhanced security, building a one-stop financial ecosystem.

UPCX Whitepaper 1.0
https://upcx.io/zh-CN/whitepaper/

UPCX Linktree
https://link3.to/upcx

In this 2025 forecast update, Wealth Megatrends, in collaboration with Weiss Ratings, offers unique insights into gold's continued upward trajectory. The release outlines Sean Brodrick's updated projection of $6,900 gold, framed within rising central bank demand, ongoing monetary volatility, and long-term shifts in asset preservation behavior. This analysis offers a distinct perspective on how this cycle compares to prior periods of financial instability and why mining equities are again drawing interest as part of a broader conversation on gold's role in today's evolving macroeconomic environment.

NEW YORK, July 03, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) between January 14, 2021 and June 5, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 29, 2025.

In this 2025 strategic update, Safe Money Report outlines a six-step framework for navigating financial instability during what Martin Weiss calls the “Age of Chaos.” With decades of historical data behind its Weiss Ratings system, the firm presents a non-promotional roadmap for evaluating liquidity, asset safety, inflation hedges, and emerging market trends in crypto and real estate. The release examines current economic conditions and how informed analysis, rather than emotion, can inform long-term wealth protection strategies.

Transaction in Own Shares

SARATOGA, Calif., July 03, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company that develops advanced imaging and artificial intelligence (“AI”) technologies that are deployed in its capsule endoscopy solutions, today announced the closing of its initial public offering of 5,500,000 shares of common stock at a public offering price of $5.00 per share. The shares began trading on the Nasdaq Capital Market on July 2, 2025 under the ticker symbol “CV.”